X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (38) 38
humans (37) 37
male (31) 31
blasting (29) 29
combustion engines (29) 29
heating (29) 29
hot-gas or combustion-product engine plants (29) 29
lighting (29) 29
mechanical engineering (29) 29
supplying combustion engines in general, with combustiblemixtures or constituents thereof (29) 29
weapons (29) 29
aged (20) 20
female (19) 19
middle aged (19) 19
prostatic neoplasms - pathology (17) 17
adult (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
chemotherapy (14) 14
index medicus (14) 14
cisplatin (13) 13
prostate cancer (12) 12
expression (10) 10
tumor cells, cultured (10) 10
breast cancer (9) 9
breast neoplasms - drug therapy (9) 9
survival (9) 9
therapy (9) 9
animals (8) 8
cell line, tumor (8) 8
drug administration schedule (8) 8
prostatic neoplasms - metabolism (8) 8
cell proliferation - drug effects (7) 7
dose-response relationship, drug (7) 7
tumors (7) 7
combination (6) 6
doxorubicin (6) 6
fluorouracil - administration & dosage (6) 6
methotrexate (6) 6
progression (6) 6
prostatic neoplasms - drug therapy (6) 6
treatment outcome (6) 6
activation (5) 5
analysis (5) 5
cancer (5) 5
carcinoma (5) 5
fluorouracil - adverse effects (5) 5
mice (5) 5
neoplasm staging (5) 5
neutropenia - chemically induced (5) 5
phosphorylation (5) 5
trial (5) 5
5-fluorouracil (4) 4
androgen receptor (4) 4
antineoplastic agents - pharmacology (4) 4
bone neoplasms - secondary (4) 4
cancer research (4) 4
cancer therapies (4) 4
cell division - drug effects (4) 4
cells (4) 4
chemotherapy, adjuvant (4) 4
cisplatin - administration & dosage (4) 4
dacarbazine (4) 4
efficacy (4) 4
egfr (4) 4
enzyme inhibitors - pharmacology (4) 4
fluorouracil (4) 4
hormonal therapy (4) 4
interferon (4) 4
melanoma (4) 4
paclitaxel - administration & dosage (4) 4
prostatic carcinoma (4) 4
receptor, epidermal growth factor - metabolism (4) 4
tamoxifen (4) 4
urology & nephrology (4) 4
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
aromatase inhibitors (3) 3
blotting, western (3) 3
bone metastasis (3) 3
breast neoplasms - pathology (3) 3
carcinoma-cells (3) 3
clinical trials (3) 3
combined modalities (3) 3
cyclophosphamide (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - analogs & derivatives (3) 3
disease models, animal (3) 3
disease-free survival (3) 3
drug therapy (3) 3
endocrinology & metabolism (3) 3
epidermal growth factor - pharmacology (3) 3
folinic acid (3) 3
fotemustine (3) 3
genetics (3) 3
health aspects (3) 3
hematology (3) 3
immunotherapy (3) 3
in-vitro (3) 3
infusion (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 01/2020, Volume 21, Issue 1, pp. 5 - 6
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1863 - 1872
Journal Article
Journal Article
by De Placido, Sabino and Gallo, Ciro and De Laurentiis, Michelino and Bisagni, Giancarlo and Arpino, Grazia and Sarobba, Maria Giuseppa and Riccardi, Ferdinando and Russo, Antonio and Del Mastro, Lucia and Cogoni, Alessio Aligi and Cognetti, Francesco and Gori, Stefania and Foglietta, Jennifer and Frassoldati, Antonio and Amoroso, Domenico and Laudadio, Lucio and Moscetti, Luca and Montemurro, Filippo and Verusio, Claudio and Bernardo, Antonio and Lorusso, Vito and Gravina, Adriano and Moretti, Gabriella and Lauria, Rossella and Lai, Antonella and Mocerino, Carmela and Rizzo, Sergio and Nuzzo, Francesco and Carlini, Paolo and Perrone, Francesco and Accurso, Antonello and Agostara, Biagio and Aieta, Michele and Alabiso, Oscar and Alicicco, Maria Grazia and Amadori, Dino and Amaducci, Laura and Amiconi, Gianna and Antuzzi, Giustino and Ardine, Mara and Ardizzoia, Antonio and Aversa, Caterina and Badalamenti, Giuseppe and Barni, Sandro and Basurto, Carlo and Berardi, Rossana and Bergamasco, Cinzia and Bidoli, Paolo and Bighin, Claudia and Biondi, Edoardo and Bisagni, Giancarlo and Boni, Corrado and Borgonovo, Karen and Botta, Mario and Bravi, Stefano and Bruzzi, Paolo and Buono, Giuseppe and Butera, Alfredo and Caldara, Alessia and Candeloro, Giampiero and Cappelletti, Claudia and Cardalesi, Cinzia and Carfora, Elisabetta and Cariello, Anna and Carrozza, Francesco and Cartenì, Giacomo and Caruso, Michele and Casadei, Virginia and Casanova, Claudia and Castori, Luigi and Cavanna, Luigi and Cavazzini, Giovanna and Cazzaniga, Marina and Chilelli, Mario and Chiodini, Paolo and Chiorrini, Silvia and Ciardiello, Fortunato and Ciccarese, Mariangela and Cinieri, Saverio and Clerico, Mario and Coccaro, Mariarosa and Comande, Mario and Corbo, Claudia and Cortino, Giuseppina and Cusenza, Stefania and Daniele, Gennaro and D'arco, Alfonso Maria and D'auria, Giuliana and Dazzi, Claudio and De Angelis, Carmine and de Braud, Filippo and De Feo, Gianfranco and De Matteis, Andrea and De Tursi, Michele and Di Blasio, Anna and di Lucca, Giuseppe and Di Lullo, Liberato and Di Rella, Francesca and Di Renzo, Gianfranco and Di Stefano, Pia and ... and GIM Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 474 - 485
Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly... 
SYSTEM | THERAPY | EFFICACY | ONCOLOGY | FOLLOW-UP | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | Breast cancer | Product development | Tamoxifen | Analysis
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2011, Volume 11, Issue 1, pp. 75 - 75
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2005, Volume 93, Issue 5, pp. 964 - 975
Urokinase-type plasminogen activator receptor (uPAR) and Epidermal Growth Factor Receptor (EGFR) are ubiquitous receptors involved in the control of a variety... 
Prostatic carcinoma | EGFR | Tyrosine kinase inhibitors | uPA | TYROSINE KINASE | HORMONAL-REGULATION | BREAST | FACTOR-ALPHA | prostatic carcinoma | tyrosine kinase inhibitors | INVASION | ZD1839 IRESSA | LINE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CARCINOMA | EXPRESSION | PROGRESSION | Laminin - pharmacology | Prostatic Neoplasms - metabolism | Phosphorylation | Cell Proliferation | Epidermal Growth Factor - physiology | Humans | Receptors, Androgen - metabolism | Receptor, ErbB-2 - metabolism | Collagen - chemistry | Male | Phosphatidylinositol 3-Kinases - metabolism | Proteoglycans - chemistry | MAP Kinase Signaling System | Dose-Response Relationship, Drug | Neoplasm Metastasis | Receptor, Epidermal Growth Factor - metabolism | Phosphatidylinositol Diacylglycerol-Lyase - metabolism | PTEN Phosphohydrolase | Phosphoric Monoester Hydrolases - biosynthesis | Inhibitory Concentration 50 | Cell Membrane - metabolism | Collagen - pharmacology | Prostatic Neoplasms - pathology | Enzyme-Linked Immunosorbent Assay | Neoplasm Invasiveness | Enzyme Inhibitors - pharmacology | Proteoglycans - metabolism | Epidermal Growth Factor - metabolism | Phosphoinositide Phospholipase C | Reverse Transcriptase Polymerase Chain Reaction | Chemotaxis | Collagen - metabolism | Proteoglycans - pharmacology | Urokinase-Type Plasminogen Activator - metabolism | Cell Line, Tumor | Laminin - chemistry | Laminin - metabolism | Quinazolines - pharmacology | Tumor Suppressor Proteins - biosynthesis | Drug Combinations | Microscopy, Fluorescence | Cell Movement
Journal Article
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 03/2008, Volume 15, Issue 1, pp. 91 - 100
Diets high in n -6 fatty acids are associated with an increased risk of bone metastasis from prostate carces (PCa). The molecular mechanism underlying this... 
CANCER-CELLS | TRABECULAR BONE | NUDE-MICE | CYCLOOXYGENASE-2 | METASTASIS | INHIBITION | METABOLISM | ONCOLOGY | GROWTH | ENDOCRINOLOGY & METABOLISM | FATTY-ACIDS | 5-LIPOXYGENASE | Tumor Necrosis Factor-alpha - metabolism | Prostatic Neoplasms - metabolism | Transcription, Genetic - drug effects | RANK Ligand - metabolism | Arachidonate 5-Lipoxygenase - genetics | Humans | Tumor Necrosis Factor-alpha - genetics | Male | Interleukin-1beta - genetics | RNA, Messenger - metabolism | Breast Neoplasms - metabolism | Cyclooxygenase 2 - genetics | Interleukin-1beta - metabolism | Bone Marrow - metabolism | Stromal Cells - drug effects | Female | Colony-Forming Units Assay | Tumor Cells, Cultured | Transforming Growth Factor alpha - metabolism | Prostatic Neoplasms - drug therapy | Bone Marrow - drug effects | Prostatic Neoplasms - pathology | Arachidonate 5-Lipoxygenase - metabolism | Epidermal Growth Factor - genetics | RNA, Messenger - genetics | Stromal Cells - metabolism | Epidermal Growth Factor - metabolism | DNA Primers | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Blotting, Western | Transforming Growth Factor alpha - genetics | RANK Ligand - genetics | Breast Neoplasms - pathology | Arachidonic Acid - pharmacology | Cyclooxygenase 2 - metabolism | Cell Proliferation - drug effects
Journal Article